Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Probing the Role of a Conserved M1 Proline Residue in 5-Hydroxytryptamine3 Receptor Gating

Hong Dang, Pamela M. England, S. Sarah Farivar, Dennis A. Dougherty and Henry A. Lester
Molecular Pharmacology June 2000, 57 (6) 1114-1122;
Hong Dang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pamela M. England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Sarah Farivar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis A. Dougherty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry A. Lester
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A conserved proline residue is found in the first transmembrane domain (M1) of every subunit in the ligand-gated ion channel superfamily. The position of this proline between the N-terminal extracellular agonist binding and the second transmembrane (M2) channel lining domains in the primary sequence suggests its possible involvement in the gating of the receptor. Replacing this proline with alanine, glycine, or leucine in the 5-hydroxytryptamine (5-HT)3A homomeric receptors expressed in Xenopus laevis oocytes resulted in the absence of 5-HT-induced whole-cell currents, although there were normal levels of specific surface [3H]granisetron ([3H]BRL-43694) binding sites. To determine what properties of the conserved proline are critical for the function of the channel, two imino acids and an α-hydroxy acid were incorporated at the proline position using the nonsense suppression method.trans-3-Methyl-proline, pipecolic acid, and leucic acid were able to replace the conserved proline to produce active channels with EC50 values similar to that for the wild-type receptor. These trends are preserved in the heteromeric receptors consisting of 5-HT3A and 5-HT3B subunits in oocytes. The prominent common feature among these residues and proline is the lack of hydrogen bond donor activity, potentially resulting in a flexible secondary structure in the M1 region. Thus, lack of hydrogen bond donor activity may be a key element in channel gating and may explain the high degree of conservation of this M1 proline.

Footnotes

  • Send reprint requests to: Dr. Henry A. Lester, Division of Biology 156-29, California Institute of Technology, Pasadena, CA 91125. E-mail: lester{at}caltech.edu

  • This work was supported by National Institutes of Health Grants MH49176, NS34407, and NS10305.

  • Abbreviations:
    M1
    transmembrane domain 1
    5-HT
    5-hydroxytryptamine (serotonin)
    5-HT3A
    5-HT3B, serotonin receptor type 3 A, B subunits
    m5-HT3A-UAG
    mouse serotonin receptor type 3 A mRNA containing the UAG stop codon rather than the M1 Pro256 codon
    nAChR
    nicotinic acetylcholine receptor
    tRNA-THG73-Xaa
    tRNA THG73 acylated with amino or hydroxy acid
    TMB-8
    8-(diethylamine)octyl-3,4,5-trimethoxybenzoate
    P3m
    trans-3-methyl-proline
    Pip
    pipecolic acid
    Lah
    leucic acid
    • Received December 9, 1999.
    • Accepted February 12, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (6)
Molecular Pharmacology
Vol. 57, Issue 6
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Probing the Role of a Conserved M1 Proline Residue in 5-Hydroxytryptamine3 Receptor Gating
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Probing the Role of a Conserved M1 Proline Residue in 5-Hydroxytryptamine3 Receptor Gating

Hong Dang, Pamela M. England, S. Sarah Farivar, Dennis A. Dougherty and Henry A. Lester
Molecular Pharmacology June 1, 2000, 57 (6) 1114-1122;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Probing the Role of a Conserved M1 Proline Residue in 5-Hydroxytryptamine3 Receptor Gating

Hong Dang, Pamela M. England, S. Sarah Farivar, Dennis A. Dougherty and Henry A. Lester
Molecular Pharmacology June 1, 2000, 57 (6) 1114-1122;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nelfinavir and PXR
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Predicting Drug Interactions with ENT1 and ENT2
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics